Nitric oxide generated by iNOS reduces deformability of Lewis lung carcinoma cells

Cancer Science

Volumn 95, Issue 4, 2004, Pages 342-347

  Igawa, Satoshi ^a   Hayashi, Izumi ^b   Tanaka, Naohiko ^b   Hiruma, Hiromi ^c   Majima, Masataka ^b   Kawakami, Tadashi ^c   Hirose, Minoru ^b   Masuda, Noriyuki ^b   Kobayashi, Hirosuke ^a,b  

^a KYUSHU UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY   (Japan)

^c KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

F ACTIN; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MESSENGER RNA; NITRATE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRITE; PHALLOIDIN; RHODAMINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOMA CELL; CELL DESTRUCTION; CELL MEMBRANE; CONTROLLED STUDY; CYTOCHEMISTRY; FILTER; FLOW RATE; IN VITRO STUDY; LEWIS CARCINOMA; LUNG CARCINOMA; LUNG METASTASIS; MALE; MOUSE; NONHUMAN; PRESSURE MEASUREMENT; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT;

ANIMALS; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; CYTOKINES; ENZYME INDUCTION; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHEOLOGY; RNA, MESSENGER; RNA, NEOPLASM; TUMOR STEM CELLS;

EID: 1942471912     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2004.tb03213.x     Document Type: Article

References (41)

1. Amber IJ, Hibbs JB, Taintor RR, Vavrin Z. Cytokine induces an L-arginine-dependent effector system in nonmacrophage cells. J Leukoc Biol 1998; 44: 58-65.
2. Harmey JH, Bucana CD, Anne WL, McDonnell S, Lynch C, Bouchier-Hayes D, Dong Z. Lipopolysaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion. Int J Cancer 2002; 101: 415-42.
3. Fostermann U, Gorsky LD, Pollock J, Ishii K, Schmidt HH, Heller M, Murad F. Hormone-induced biosynthesis of endothelium-derived relaxing factor/nitric oxide-like material in NIE-115 neuroblastoma cells requires calcium and calmodulin. Mol Pharmacol 1990; 38: 7-13.
4. Fast DJ, Lynch RC, Leu RW. Nitric oxide production by tumor targets in response to TNF: paradoxical correlation with susceptibility to TNF-mediated cytotoxicity without direct involvement in the cytotoxic mechanism. J Leukoc Biol 1992; 52: 255-61.
5. Ambs S, Hussain SP, Harris CC. Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J 1997; 11: 443-9.
6. Ambs S, Merriam WG, Ogunfusika MO, Bennett WP, Ishibe N, Hussain SP, Tzeng EE, Geller DA, Billiar TR, Harris CC. p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells. Nat Med 1998; 4: 1371-6.
7. Ambs S, Bennett WP, Merriam WG, Ogunfusika MO, Oser SM, Khan MA, Jones RT, Harris CC. Vascular endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p53. Br J Cancer 1998; 78: 233-9.
8. Xie K, Fidler IJ. Therapy of cancer metastasis by activation of the inducible nitric oxide syntheses. Cancer Metastasis Rev 1998; 17: 5555-75.
9. Xie K, Dong Z, Fidler IJ. Activation of nitric oxide syntheses gene for inhibition of cancer metastasis. J Leukoc Biol 1996; 59: 797-803.
10. Fukumura D, Jain RK. Role of nitric oxide in angiogenesis and microcirculation in tumors. Cancer Metastasis Res 1998; 17: 77-89.
11. Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG. Nitric oxide syntheses activity in human breast cancer. Br J Cancer 1995; 72: 41-4.
12. Filder IJ. Critical factors in the biology of human cancer metastasis. Cancer Res 1990; 2: 169-77.
13. Nicolson G. Molecular mechanisms of cancer metastasis: tumor cells and host-organ properties important in metastasis to specific secondary sites. Biochim Biophys Acta 1986; 984: 175-224.
14. Ochalek T, Nordt FJ, Tullberg K, Burger MM. Correlation between cell deformability and metastatic potential in B16-F1 melanoma cell variants. Cancer Res 1988; 48: 5124-8.
15. Tullberg KF, Burger MM. Selection of B16 melanoma cells with increased metastatic potential and low intercellular cohesion using Nuclepore filters. Invasion Metastasis 1985; 5: 1-15.
16. Erkell LJ, Ryd W, Hagmar B. Comments on the filter for tumor cell deformability. Invasion Metastasis 1982; 2: 260-7.
17. Kobayashi H, Tailin C, Ando M, Imasaki T, Mitufuji H, Imasaki T, Tomita T. Nitric oxide released from iNOS in polymorphonuclear leukocytes makes them deformable in an autocrine manner. Nitric Oxide 2002; 7: 221-7.
18. Kimura H, Ogura T, Kurashima Y, Weisz A, Esumi H. Effects of nitric oxide donors on vascular endothelial growth factor gene induction. Biochem Biophys Res Commun 2002; 296: 976-82.
19. Ni CW, Wang DL, Lien SC, Cheng JJ, Chao YJ, Hsieh HJ. Activation of PKC-epsilon and ERK1/2 participates in shear-induced endothelial MCP-1 expression that is repressed by nitric oxide. J Cell Physiol 2003; 195: 428-34.
20. Eisenbach L, Hollander N, Greenfeld L, Yakor H, Segal S, Feldman M. The differential expression of H-2K versus H-2D antigens, distinguishing high-metastatic from low-metastatic clones, is correlated with the immunogenic properties of the tumor cells. Int J Cancer 1984; 34: 567-73.
21. Young SJ, Ali SA, Taub DD, Ress RC. Chemokines induce migrational responses in human breast carcinoma cell lines. Int J Cancer 1997; 71: 257-66.
22. Wang JM, Deng X, Gong W, Su S. Chemokines and their role in tumor growth and metastasis. J Immunol Methods 1998; 220: 1-17.
23. Sato Y, Walley KR, Klut ME, English D, D'yachkova Y, Hogg JC, van Eeden SF. Nitric oxide reduces the sequestration of polymorphonuclear leukocytes in lung by changing deformability and CD18 expression. Am J Respir Crit Care Med 1999; 159: 1469-76.
24. Liu SM, Sundqvist T. Involvement of nitric oxide in permeability alteration and F-actin redistribution induced by phorbol myristate acetate in endothelial cells. Exp Cell Res 1995; 221: 289-93.
25. Block W, Hoever D, Reitze D, Kopalek L, Addicks K. Exogenously supplied nitric oxide influences the dilation of the capillary microvasculature in vivo. Agents Actions Suppl 1995; 45: 150-6.
26. Mandeville JT, Maxfield FR. Calcium and signal transudation in granulocytes. Curr Opin Hematol 1996; 3: 63-70.
27. Brown GM, Brown DM, Donaldson K, Drost E, MacNee W. Neutrophil sequestration in rat lungs. Thorax 1995; 50: 661-7.
28. Selby C, Drost E, Wraith PK, MacNee W. In vitro neutrophil sequestration within lungs of humans is determined by in vitro filterability. Am J Physiol 1991; 71: 1996-2003.
29. Ahmet H, Mark E, Eric C. Effect of proinflammatory cytokines and bacterial toxins on neutrophil theological properties. Crit Care Med 1998; 26: 1677-82.
30. Erzurum SC, Downey GP, Doherty DE, Schwab B, Elson EL, Worthen GS. Mechanisms of lipopolysaccharide-induced neutrophil retention. Relative contributions of adhesive and cellular mechanical properties. J Immunol 1992; 149: 154-62.
31. Inano H, English D, Doerschuk CM. Effect of zymosan- activated plasma on the deformability of rabbit polymorphonuclear leukocytes. J Appl Physiol 1992; 73: 1370-6.
32. Loibl S, Minckwitz G, Weber S. Expression of endothelial and inducible nitric oxide syntheses in benign and malignant lesions of the breast and measurement of nitric oxide using election paramagnetic resonance spectroscopy. Cancer 2002; 95: 1191-8.
33. Mortensen K, Holck S, Christensen IJ. Endothelial nitric oxide syntheses in peritumoral microvessels is a favorable prognostic indicator in premenopausal breast cancer patients. Clin Cancer Res 1999; 5: 1093-7.
34. Jadeski LC, Hum KO, Chakraborty C, Lala PK. Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis. Int J Cancer 2000; 86: 30-9.
35. Lala PK, Chakraborty C. Role of nitric oxide in carcinogenesis and tumor progression. Lancet Oncol 2001; 2: 149-56.
36. Xu W, Liu LZ, Loizidou M, Ahmed M, Charles I. The role of nitric oxide in cancer. Cell Research 2002; 12: 311-20.
37. Xie K, Bielenberg D, Huang S, Xu L, Salas T, Juang SH, Dong Z, Fidler IJ. Abrogation of tumorigenicity and metastasis of murine and human tumor cells by transfection with the murine IFN-beta gene: possible role of nitric oxide. Clin Cancer Res 1997; 1: 2283-94.
38. Reveneau S, Arnould L, Jolimoy G, Hilpert S, Lejeune P, Saint-Giorgio V, Belichard C, Jeannin, JF. Nitric oxide syntheses in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptors. Lab Invest 1999; 79: 1215-25.
39. Vakkala M, Kahlos K, Lakari E, Paakko P, Kinnula V, Soini Y. Inducible nitric oxide syntheses expression, apoptosis, and angiogenesis in situ and invasive breast carcinomas. Clin Cancer Res 2000; 6: 2408-16.
40. Edwards P, Cendan JC, Topping D, Moldawer LL. Tumor cell nitric oxide inhibits cell growth in vitro, but stimulates tumorigenesis and experimental lung metastasis in vivo. J Surg Res 1996; 63: 49-52.
41. Mohammed EM, Ava S, Rhian MT, Ernesto LS. Antiproliferative effect of L-NAME on rat vascular smooth muscle cells. Life Sci 2000; 67: 1613-23.